當(dāng)前位置：首頁 JCRQ1 期刊介紹(非官網(wǎng))

Cellular And Molecular Gastroenterology And HepatologySCIE

國際簡稱：CELL MOL GASTROENTER 參考譯名：細(xì)胞和分子胃腸病學(xué)和肝病學(xué)

中科院分區(qū)
1區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q1

基本信息：: ISSN：2352-345X; E-ISSN：2352-345X; 是否OA：開放; 是否預(yù)警：否; TOP期刊：是

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：Elsevier; 出版語言：English; 出版周期：8 issues/year; 出版年份：2015; 研究方向：Medicine-Gastroenterology

評價(jià)信息：: 影響因子：7.1; CiteScore指數(shù)：13; SJR指數(shù)：2.702; SNIP指數(shù)：1.356

發(fā)文數(shù)據(jù)：: Gold OA文章占比：75.23%; 研究類文章占比：84.82%; 年發(fā)文量：112; 自引率：0.0277...; 開源占比：0.8422; 出版撤稿占比：0; 出版國人文章占比：0.04; OA被引用占比：1

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Cellular And Molecular Gastroenterology And Hepatology期刊介紹

CMGH is the newest peer-reviewed journal published by the American Gastroenterological Association (AGA), joining Gastroenterology and Clinical Gastroenterology and Hepatology. The mission of CMGH is to publish impactful digestive biology research that ranges from mechanisms of normal function to pathobiology and covers a broad spectrum of themes in gastroenterology, hepatology, and pancreatology. The journal reports the latest advances in cell biology, immunology, physiology, microbiology, genetics, and neurobiology of gastrointestinal, hepatobiliary, and pancreatic health and disease. The research CMGH publishes is hypothesis driven, mechanistically novel, and appropriately designed and powered. Studies published in CMGH address important questions using tissues or cells from patients or animal models in order to make fundamental discoveries and translate them to human disease.

期刊簡介Cellular And Molecular Gastroenterology And Hepatology期刊介紹

《Cellular And Molecular Gastroenterology And Hepatology》自2015出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間： 19 Weeks
國際TOP期刊
醫(yī)學(xué)
GASTROENTEROLOGY & HEPATOLOGY
SCIE
中科院1區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Cellular And Molecular Gastroenterology And Hepatology Cite Score數(shù)據(jù)

CiteScore：13
SJR：2.702
SNIP：1.356

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Gastroenterology	Q1	10 / 167	94%
大類：Medicine 小類：Hepatology	Q1	11 / 82	87%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價(jià)期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價(jià)。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Cellular And Molecular Gastroenterology And Hepatology 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	1區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	2區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級劃分的期刊評價(jià)標(biāo)準(zhǔn)。它為我國科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評價(jià)國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Cellular And Molecular Gastroenterology And Hepatology JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q1	15 / 143	89.9%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q1	16 / 143	89.16%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評價(jià)期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計(jì)

國家/地區(qū)數(shù)量
USA288
Japan28
GERMANY (FED REP GER)23
CHINA MAINLAND22
Canada22
France20
England17
Netherlands14
Spain12
Switzerland10

本刊中國學(xué)者近年發(fā)表論文

1、Gut Microbiota-Derived Glutamine Attenuates Liver Ischemia/Reperfusion Injury via Macrophage Metabolic Reprogramming
Author: Lu, Tianfei; Li, Qing; Lin, Weiwei; Zhao, Xianzhe; Li, Fu; Ji, Jianmei; Zhang, Yu; Xu, Ning

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 5, pp. 1255-1275. DOI: 10.1016/j.jcmgh.2023.01.004
2、Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer Macrophages
Author: Du, Li; Ji, Yichun; Xin, Bing; Zhang, Jiemeng; Lu, Li-Chun; Glass, Christopher K.; Feng, Gen-Sheng

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 6, pp. 1351-1369. DOI: 10.1016/j.jcmgh.2023.02.011
3、Mechanistic Insight and Clinical Implications of Ischemia/Reperfusion Injury Post Liver Transplantation
Author: Liu, Jiang; Man, Kwan

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 6, pp. 1463-1474. DOI: 10.1016/j.jcmgh.2023.03.003
4、Single-cell Transcriptomics Reveals Early Molecular and Immune Alterations Underlying the Serrated Neoplasia Pathway Toward Colorectal Cancer
Author: Zhou, Yu-Jie; Lu, Xiao-Fan; Chen, Huimin; Wang, Xin-Yuan; Cheng, Wenxuan; Zhang, Qing-Wei; Chen, Jin-Nan; Wang, Xiao-Yi; Jin, Jing-Zheng; Yan, Fang-Rong; Chen, Haoyan; Li, Xiao-Bo

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 393-424. DOI: 10.1016/j.jcmgh.2022.10.001
5、Sex Differences in Genomic Features of Hepatitis B-Associated Hepatocellular Carcinoma With Distinct Antitumor Immunity
Author: Xu, Chungui; Cheng, Shaoyan; Chen, Kun; Song, Qianqian; Liu, Chang; Fan, Chunsun; Zhang, Ruochan; Zhu, Qing; Wu, Zhiyuan; Wang, Yuting; Fan, Jian; Zheng, Hongwei; Lu, Lingling; Chen, Taoyang; Zhao, Hong; Jiao, Yuchen; Qu, Chunfeng

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 327-354. DOI: 10.1016/j.jcmgh.2022.10.009
6、GLIS2 Prevents Hepatic Fibrosis by Competitively Binding HDAC3 to Inhibit Hepatic Stellate Cell Activation
Author: Zhang, Haoye; Zhou, Pengcheng; Xing, Wu; Chen, Limin; Zhou, Yangmei; Yang, Hui; Fu, Kangkang; Liu, Zhenguo

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 355-372. DOI: 10.1016/j.jcmgh.2022.10.015
7、HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation
Author: Yuan, Jingsheng; Lv, Tao; Yang, Jian; Wu, Zhenru; Yan, Lvnan; Yang, Jiayin; Shi, Yujun; Jiang, Li

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 307-325. DOI: 10.1016/j.jcmgh.2022.10.005
8、DCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis
Author: Yan, Rui; Li, Jianjian; Xiao, Zeru; Fan, Xiaona; Liu, Heshu; Xu, Ying; Sun, Ruya; Liu, Jian; Yao, Jiannan; An, Guangyu; Shi, Yan; Ge, Yang

Journal: CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY. 2023; Vol. 15, Issue 2, pp. 463-485. DOI: 10.1016/j.jcmgh.2022.10.013